UK Mounjaro shortages as Lilly raises price and offers discount

Patients across the United Kingdom are facing shortages of the weight loss and diabetes drug Mounjaro as its US manufacturer moves to raise the UK list price from September 1 and then agreed a discounted supply deal for pharmacies. The announcement prompted a run on supplies, with wholesalers temporarily paused and high street pharmacies prioritising existing patients while warning against bulk buying.

Eli Lilly originally said the list price could rise by as much as 170 percent, taking the cost of the highest monthly dose from about 122 pounds to 330 pounds. The company subsequently offered UK suppliers a discounted rate of 247.50 pounds for the top 15mg dose, which industry leaders say should limit but not eliminate the likely increase for patients. Eli Lilly said it is "working with private providers on commercial arrangements to maintain affordability" and that allocations are in place for pharmacies and providers that order stock from the company.

Pharmacies and campaigners reported sharp spikes in demand after the price announcement, prompting some suppliers to restrict orders. The National Pharmacy Association said the rise had caused "short‑term pressures on supply" and...